Bioleaders Corporation (142760) - Total Liabilities

Latest as of March 2026: ₩11.39 Billion KRW ≈ $7.72 Million USD

Based on the latest financial reports, Bioleaders Corporation (142760) has total liabilities worth ₩11.39 Billion KRW (≈ $7.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bioleaders Corporation - Total Liabilities Trend (2015–2025)

This chart illustrates how Bioleaders Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore 142760 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Bioleaders Corporation Competitors by Total Liabilities

The table below lists competitors of Bioleaders Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Banka BioLoo Limited NSE:BANKA	India	Rs494.26 Million
SACCHERIA F.LLI FRANCES. F:YV1	Germany	€8.02 Million
Sequoia Financial Group Ltd AU:SEQ	Australia	AU$21.27 Million
Tarjar Xairo Socimi SA MC:YTAR	Spain	€4.95 Million
Nexen Corp KO:005725	Korea	₩2.98 Trillion
Tecnisa S.A SA:TCSA3	Brazil	R$905.84 Million
MISSION GROUP PLC LS -10 F:M7K	Germany	€73.72 Million
KYM Holdings Bhd KLSE:8362	Malaysia	RM46.63 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Bioleaders Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bioleaders Corporation assets under control.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bioleaders Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bioleaders Corporation (2015–2025)

The table below shows the annual total liabilities of Bioleaders Corporation from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩12.04 Billion ≈ $8.16 Million	-51.73%
2024-12-31	₩24.94 Billion ≈ $16.90 Million	+87.86%
2023-12-31	₩13.28 Billion ≈ $9.00 Million	-89.52%
2022-12-31	₩126.73 Billion ≈ $85.88 Million	-11.83%
2021-12-31	₩143.74 Billion ≈ $97.41 Million	-10.22%
2020-12-31	₩160.09 Billion ≈ $108.49 Million	+28.80%
2019-12-31	₩124.30 Billion ≈ $84.23 Million	-4.24%
2018-12-31	₩129.79 Billion ≈ $87.96 Million	+5284.50%
2017-12-31	₩2.41 Billion ≈ $1.63 Million	-41.92%
2016-12-31	₩4.15 Billion ≈ $2.81 Million	+4.09%
2015-12-31	₩3.99 Billion ≈ $2.70 Million	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$9.97 Million

₩14.72 Billion KRW

Market Cap Rank

#27050 Global

#2034 in Korea

Share Price

₩349.00

Change (1 day)

-16.51%

52-Week Range

₩349.00 - ₩1850.00

All Time High

₩24990.00